AMPE — Ampio Pharmaceuticals Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
AMEX HALT ADDITIONAL INFORMATION LAST 1.070000
AMEX RESUMED
AMEX HALT ADDITIONAL INFORMATION LAST 0.919900
Brief: Ampio Receives U.S. FDA Approval Of Special Protocol Assessment Of A Clinical Protocol
Brief: Ampio Pharmaceuticals' CFO, Treasurer And Secretary Thomas Chilcott Resigns
Brief: Ampio Pharmaceuticals Inc - Net Loss Of $0.05 Per Common Share For Q1 Of 2019
Brief: Ampio Pharmaceuticals Provides Regulatory Update
Brief: Ampio Pharmaceuticals Says May Sell Shares From Time To Time Up To $24.65 Mln
Brief: Ampio Pharmaceuticals Provides Corporate Update
Brief: Ampio Updates Regulatory Status For Ampion
Brief: Ampio Updates Status Of Pivotal Clinical Trial Of Ampion To Be Carried Out Under A SPA
Ampio Pharma: Down as FDA suggests additional study for lead drug
Brief: Ampio Pharmaceuticals Updates Regulatory Status For Ampion
Brief: Ampio updates regulatory and clinical status for Ampion
Brief: Ampio Pharmaceuticals Says David Bar-Or To Retire As Chief Scientific Officer
Ampio Pharma: Plunges on stock offering
Brief: Ampio Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock And Warrants
Brief: Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock And Warrants
U.S. STOCKS ON THE MOVE-Tesla, Amazon, Halliburton, Papa John's, Illinois Tool Works